Bayer Aktiengesellschaft (WSE:BAY)

Market Cap	87.73B
Revenue (ttm)	199.42B
Net Income (ttm)	-10.92B
Shares Out	n/a
EPS (ttm)	-11.13
PE Ratio	n/a
Forward PE	n/a
Dividend	0.48 (0.53%)
Ex-Dividend Date	Apr 28, 2025

Volume	105
Average Volume	70
Open	91.54
Previous Close	92.94
Day's Range	89.54 - 91.54
52-Week Range	78.97 - 132.50
Beta	n/a
RSI	38.09
Earnings Date	Mar 5, 2025

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skinca...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1863
• Employees: 90,587
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: BAY

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.

Financial numbers in EUR